The newly issued patent further confirms the uniqueness and effectiveness of Sofwave’s SUPERB Technology.
Israel - July 13, 2023 —
Sofwave Medical, an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, is on track to become the industry leader. The company is thrilled to announce that its proprietary SUPERB (Synchronous Ultrasound Parallel Beam) Technology has received additional US Patent Protection, another in a portfolio of patents and patents pending globally that protect the features and capabilities of the technology.
This second US technology patent is directed to SUPERB’s ultrasound and cooling technology and comes in addition to the previously issued IP in China, Hong Kong, Australia, and Israel. Besides solidifying the company’s commitment to pioneering advancements in the industry, the patent ensures IP protection of SUPERB’s underlying proprietary design, innovation, and configuration with key elements like the device’s heating and cooling array covered.
Sharing his excitement over the recognition, Sofwave’s Chief Executive Officer Louis Scafuri said, “We remain excited for Sofwave’s prospects as our award-winning non-surgical skin and collagen remodeling device continues to earn accolades and expanding industry adoption.”
With an additional 31 patents pending globally, Sofwave Medical is dedicated to further building the IP around its revolutionary technology. The company ensures clinicians have access to innovative skincare solutions that meet clients’ needs and patients have access to the best aesthetic medical treatments possible. This transformative technology, which is also FDA-cleared, harnesses the power of energy-based non-invasive treatments to address skin laxity, a natural result of aging but a major hindrance to youthful, radiant skin.
Naturally, people want to maintain their youthful appearance, but the magic of radiant skin starts to fade with age as collagen and elastin begin to wear, leaving loose skin, sagging skin, and lax skin in their wake. While genetics play a role in the body’s skin laxity, age and other external factors like poor lifestyle habits come into play. As a result, many people lose confidence in their appearance and find ways to cover up their skin laxity. For many years, desperation has driven people to opt for intrusive procedures that have no guarantee of providing long-term results.
Recognizing a growing need as non-invasive procedures become more preferred, Sofwave Medical developed its state-of-the-art solution. SUPERB Technology is a clinically proven, unique, and practical approach that remodels collagen leading to improvements in facial lines and wrinkles, lifting the eyebrow and lax submental tissue and neck tissue, and offering short-term improvement in the appearance of cellulite. Sofwave’s SUPERB Technology emits precise ultrasound energy that passes through the skin’s surface, heating the mid-dermal tissue at the right depth and temperature to rejuvenate collagen fibers and improve skin appearance. The company’s Sofcool cooling mechanism protects the skin from burning during the procedure, and after a single 45-minute treatment, patients begin to show significant improvements.
With this breakthrough technology, physicians can access an innovative, effective, and safe aesthetic solution that provides their patients with the desired results. Sofwave Medical vows to continue driving innovation in the industry with safe and effective skincare solutions for patients and clinicians. As the company basks in the excitement of gaining additional US Patent Protection, it invites people to learn more about its proprietary technology and experience the power of energy-based non-invasive aesthetic treatments.
Contact Info:
Name: Bella Gitnik
Email: Send Email
Organization: Sofwave Medical
Address: Israel
Website: https://sofwave.com
Release ID: 89102075
If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com. Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.
